The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 07, 2015
Filed:
Aug. 09, 2011
Applicants:
Mikiko Morita, Aichi, JP;
Shuzo Watanabe, Aichi, JP;
Inventors:
Mikiko Morita, Aichi, JP;
Shuzo Watanabe, Aichi, JP;
Assignee:
Raqualia Pharma Inc., Aichi, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 403/12 (2006.01); A61K 31/506 (2006.01); C07D 239/47 (2006.01); A61K 45/06 (2006.01); C07D 401/14 (2006.01); C07D 405/12 (2006.01); C07D 409/12 (2006.01); C07D 413/12 (2006.01); C07D 417/12 (2006.01); A61K 31/517 (2006.01); A61K 31/538 (2006.01); C07D 401/12 (2006.01); C07D 403/04 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 487/08 (2006.01); C07D 495/04 (2006.01);
U.S. Cl.
CPC ...
C07D 239/47 (2013.01); A61K 31/506 (2013.01); A61K 45/06 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); A61K 31/517 (2013.01); A61K 31/538 (2013.01); C07D 401/12 (2013.01); C07D 403/04 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01); C07D 487/08 (2013.01); C07D 495/04 (2013.01);
Abstract
The present invention relates to acyl piperazine derivatives which have blocking activities of voltage gated sodium channels as the TTX-S channels, and which are useful in the treatment or prevention of disorders and diseases in which voltage gated sodium channels are involved. The invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which voltage gated sodium channels are involved.